Childhood cancers: trials for referral
2718 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 2718 open trials.
Phase 27 sites
RecruitingUnited States
NCT06057948
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
Not yet recruitingUnited States
NCT07389278
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
Sabine Mueller, MD, PhD
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/22 sites
RecruitingUnited States
NCT04959175
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingUnited States
NCT07524530
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 12 sites
RecruitingUnited States
NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT06303193
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 213 sites
RecruitingBrazil, United States
NCT07226453
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
University of California, San Francisco
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 117 sites
RecruitingChina, United States
NCT04192344
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Abbisko Therapeutics Co, Ltd
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 4130 sites
RecruitingArgentina, Austria, Bulgaria, Brazil, Canada, China
NCT04877522
Asciminib Roll-over Study
Novartis Pharmaceuticals
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 23 sites
RecruitingUnited States
NCT07447076
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Sabine Mueller, MD, PhD
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/22 sites
RecruitingUnited States
NCT05588141
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 210 sites
RecruitingDenmark, Spain, United Kingdom, Lithuania, Netherlands, Norway
NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Jakob Stenman
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT05470491
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
National Cancer Institute (NCI)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
Not yet recruitingChina
NCT07922902
Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT
zhaoxiaohui
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 1/22 sites
RecruitingUnited States
NCT05436418
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govNo phase0 sites
Not yet recruiting
NCT07921550
Venetoclax Plus Inotuzumab Reduced-Intensity Induction Sequentially Followed by Blinatumomab in B-ALL
Institute of Hematology & Blood Diseases Hospital, China
Pre-treatment window Registry sentence: “Newly diagnosed, untreated (except prednisone/hydroxyurea) Ph-negative ALL by morphology and immunophenotype.”
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 1/24 sites
RecruitingUnited States
NCT07437963
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingUnited States
NCT07790913
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
St. Jude Children's Research Hospital
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingGermany
NCT07108868
A Phase I Dose Finding Study of MB-CART2219.1
University Hospital Tuebingen
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 1/275 sites
RecruitingAustralia, Belgium, Canada, Switzerland, Germany, Spain
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nuvalent Inc.
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 281 sites
RecruitingUnited States
NCT06900595
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
National Cancer Institute (NCI)
Pre-treatment window Registry sentence: “Treatment naïve patients will be allowed.”
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited States
NCT07923370
Facial Expression Awareness Training to Understand and Recognize Emotions
Children's Hospital of Philadelphia
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 383 sites
RecruitingBelgium, Canada, China, Costa Rica, France, United Kingdom
NCT05862285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Hoffmann-La Roche
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 213 sites
RecruitingUnited States
NCT05333458
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
National Cancer Institute (NCI)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 1/230 sites
RecruitingAustralia, Brazil, China, Czechia, Germany, Denmark
NCT05533775
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Hoffmann-La Roche
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 1/216 sites
RecruitingCanada, United States
NCT05734066
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Jazz Pharmaceuticals
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 39 sites
RecruitingGermany, Spain, Netherlands, United States
NCT07223021
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 11 site
Not yet recruitingUnited States
NCT07701889
Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic Malignancies
Roswell Park Cancer Institute
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 3419 sites
RecruitingCanada, Puerto Rico, United States
NCT05675410
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
Pre-treatment window Registry sentence: “Patients with newly diagnosed untreated histologically confirmed classic Hodgkin lymphoma (cHL) (nodular sclerosis, mixed cellularity, lymphocyte-rich, or lymphocyte-depleted, or not otherwise specified \[NOS\]) with stage I or II disease”
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States267 open trials
- China69 open trials
- Canada60 open trials
- France49 open trials
- Spain46 open trials
- Australia44 open trials
- Italy41 open trials
- United Kingdom35 open trials
- Germany33 open trials
- Denmark29 open trials
- South Korea28 open trials
- Netherlands26 open trials
- Japan22 open trials
- Poland20 open trials
- Belgium20 open trials
- Czechia16 open trials
- Taiwan16 open trials
- Sweden16 open trials
- Israel16 open trials
- Hungary15 open trials
- Austria14 open trials
- Brazil13 open trials
- New Zealand11 open trials
- Greece10 open trials
- Norway10 open trials
- Finland9 open trials
- Türkiye8 open trials
- Puerto Rico7 open trials
- Romania6 open trials
- Portugal6 open trials
- Slovakia6 open trials
- Switzerland6 open trials
- Russia5 open trials
- Singapore5 open trials
- Argentina4 open trials
- Thailand4 open trials
- Mexico4 open trials
- Lithuania3 open trials
- Chile3 open trials
- Egypt3 open trials
- Bulgaria2 open trials
- Malaysia2 open trials
- Colombia2 open trials
- Slovenia2 open trials
- Ireland2 open trials
- Saudi Arabia2 open trials
- India2 open trials
- Lebanon1 open trial
- Vietnam1 open trial
- Costa Rica1 open trial
- Ukraine1 open trial
- Jordan1 open trial
- Peru1 open trial
- Réunion1 open trial
- Georgia1 open trial
- South Africa1 open trial
- Serbia1 open trial
- Zimbabwe1 open trial
- Uganda1 open trial
- Croatia1 open trial
- Belarus1 open trial
- Moldova1 open trial
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Cincinnati Children's Hospital Medical Center
Cincinnati, United States
229 trials · 32 publications · ROR
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, United States
3 trials · 45 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Closed for recruitment
NCT04150497 · Phase 1/2 · Spain, France, Italy, United States
Source: ClinicalTrials.govNew in the registry
Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
NCT07924384 · No phase · France
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions
NCT04549571 · No phase · United States
Source: ClinicalTrials.govClosed for recruitment
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
NCT05151718 · No phase · France
Source: ClinicalTrials.govClosed for recruitment
NCT04925479 · Phase 1/2 · China, Germany, France, Greece, Italy, Japan
Source: ClinicalTrials.govOpened for recruitment
Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection
NCT07833046 · No phase · China
Source: ClinicalTrials.govNew in the registry
Endoscopic Ultrasound Shear Wave Elastography in Solid Pancreatic Lesions
NCT07924540 · No phase · Romania
Source: ClinicalTrials.govNew in the registry
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
2024-515962-15-00 · Phase 2 · France
Source: EU CTISNew in the registry
Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT
NCT07922902 · No phase · China
Source: ClinicalTrials.govNew in the registry
Facial Expression Awareness Training to Understand and Recognize Emotions
NCT07923370 · No phase · United States
Source: ClinicalTrials.govNew in the registry
Multi-omics Profiling of Relapsed Extranodal Natural Killer (NK)/T-cell Lymphoma
NCT07920757 · No phase · China
Source: ClinicalTrials.govClosed for recruitment
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035 · Phase 3 · Austria, Australia, Belgium, Canada, Switzerland, Czechia
Source: ClinicalTrials.govNew in the registry
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
NCT07920770 · No phase · China
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
NCT04946279 · No phase · United States
Source: ClinicalTrials.govNew in the registry
ProsBiT: Turkish Prostate Biopsy Study
NCT07919379 · No phase
Source: ClinicalTrials.govNew in the registry
Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
NCT07919470 · No phase · China
Source: ClinicalTrials.govNew in the registry
Stereotactic Body Radiotherapy for the Treatment of OPD
NCT03256981 · Phase 2/3 · Switzerland, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.gov
Show more
Status changed: Recruiting → By invitation only
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051 · Phase 1 · Germany
Source: ClinicalTrials.govClosed for recruitment
NCT07134088 · Phase 1/2 · France, Italy, Japan, Netherlands, United States
Source: ClinicalTrials.govOpened for recruitment
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
NCT07032285 · Phase 2 · Spain
Source: ClinicalTrials.govOpened for recruitment
NCT06581406 · Phase 2/3 · Australia, Germany, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 1
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
NCT06485947 · Phase 1 · Austria, Germany, Spain, France, Italy, Netherlands
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567 · Phase 1/2 · Czechia, Germany, Denmark, Spain, France, Italy
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
NCT06485908 · Phase 1/2 · France
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
NCT06246643 · Phase 2 · Spain, France, Japan, South Korea, Taiwan
Source: ClinicalTrials.govPhase changed: Phase 2 → Phase 1/2
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
NCT06094101 · Phase 1/2 · Germany
Source: ClinicalTrials.govClosed for recruitment
NCT05830084 · Phase 1 · Australia, Denmark, Spain, France, Italy, Netherlands
Source: ClinicalTrials.govClosed for recruitment
NCT05625399 · Phase 3 · Austria, Australia, Belgium, Brazil, Canada, Switzerland
Source: ClinicalTrials.govOpened for recruitment
NCT05533697 · Phase 1/2 · Australia, Germany, Spain, United Kingdom, Italy, Poland
Source: ClinicalTrials.govClosed for recruitment
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
NCT05417789 · Phase 3 · Austria, Belgium, Canada, Switzerland, Spain, France
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
NCT05440786 · Phase 2 · Australia, Germany, Spain, France, Italy, Japan
Source: ClinicalTrials.govPhase changed: Phase 2 → Phase 1/2
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
NCT05384821 · Phase 1/2 · France
Source: ClinicalTrials.govOpened for recruitment
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
NCT05465174 · Phase 2 · Australia, Germany, France, Netherlands, United States
Source: ClinicalTrials.govOpened for recruitment
Use of GnRHa During Chemotherapy for Fertility Protection
NCT05328258 · Phase 3 · Sweden
Source: ClinicalTrials.govClosed for recruitment
NCT05217446 · Phase 2 · Australia, Belgium, Canada, Czechia, Germany, Denmark
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 1
NCT05216835 · Phase 1 · Canada, Denmark, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
NCT05206357 · Phase 1 · Australia, Belgium, Canada, Czechia, Germany, Spain
Source: ClinicalTrials.govStatus changed: Recruiting → By invitation only
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309 · Phase 2 · Austria, Australia, Belgium, Canada, Switzerland, Germany
Source: ClinicalTrials.govOpened for recruitment
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
NCT04793919 · Phase 2 · Belgium, Czechia, Germany, Denmark, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 3 → Phase 4
NCT04877522 · Phase 4 · Argentina, Austria, Bulgaria, Brazil, Canada, China
Source: ClinicalTrials.govOpened for recruitment
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
NCT04758000 · Phase 2 · Italy
Source: ClinicalTrials.govStatus changed: Recruiting → By invitation only
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
NCT04646187 · Phase 4 · Belgium, Spain, Netherlands
Source: ClinicalTrials.govPhase changed: Phase 2 → Early Phase 1
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
NCT04655404 · Early Phase 1 · Australia, Canada, Germany, New Zealand, United States
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
NCT04758533 · Phase 1/2 · Spain
Source: ClinicalTrials.govPhase changed: Phase 2/3 → Phase 3
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT04307576 · Phase 3 · Belgium, Germany, Denmark, Estonia, Spain, Finland
Source: ClinicalTrials.govOpened for recruitment
NCT04150497 · Phase 1/2 · Spain, France, Italy, United States
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
NCT03967223 · Phase 2 · Canada, Spain, France, United Kingdom, Italy, Netherlands
Source: ClinicalTrials.govOpened for recruitment
NCT03838042 · Phase 1/2 · Austria, Australia, Switzerland, Germany, France, Netherlands
Source: ClinicalTrials.govOpened for recruitment
NCT03643276 · Phase 3 · Austria, Australia, Switzerland, Czechia, Germany, Israel
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 2
NCT03709680 · Phase 2 · Brazil, Canada, Czechia, Germany, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 1
NCT03715933 · Phase 1 · Spain, France, United Kingdom, Italy, Netherlands, United States
Source: ClinicalTrials.govClosed for recruitment
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899 · Phase 1/2 · Germany, Spain, France, United Kingdom, Italy, Netherlands
Source: ClinicalTrials.govClosed for recruitment
NCT03363373 · Phase 2 · Canada, Germany, Denmark, Spain, France, United Kingdom
Source: ClinicalTrials.govOpened for recruitment
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT03590171 · Phase 2 · Austria, Australia, Belgium, Czechia, Germany, Denmark
Source: ClinicalTrials.govClosed for recruitment
Paediatric Hepatic International Tumour Trial
NCT03017326 · Phase 3 · Austria, Belgium, Switzerland, Czechia, Germany, Spain
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 2
NCT00777036 · Phase 2 · Argentina, Australia, Brazil, Canada, Germany, Spain
Source: ClinicalTrials.govPhase changed: Phase 3 → Phase 1
NCT02735083 · Phase 1 · Spain, France, United Kingdom, Japan, United States
Source: ClinicalTrials.govClosed for recruitment
NCT02735083 · Phase 1 · Spain, France, United Kingdom, Japan, United States
Source: ClinicalTrials.govClosed for recruitment
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
NCT02066220 · Phase 2/3 · Austria, Belgium, Switzerland, Czechia, Germany, Denmark
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
NCT02637687 · Phase 1/2 · Australia, Canada, Switzerland, China, Czechia, Germany
Source: ClinicalTrials.govClosed for recruitment
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
NCT04758000 · Phase 2 · Italy
Source: ClinicalTrials.govOpened for recruitment
NCT05830084 · Phase 1 · Australia, Denmark, Spain, France, Italy, Netherlands
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
NCT06581406 · Phase 2/3 · Australia, Germany, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.govOpened for recruitment
NCT05625399 · Phase 3 · Austria, Australia, Belgium, Brazil, Canada, Switzerland
Source: ClinicalTrials.govClosed for recruitment
NCT05533697 · Phase 1/2 · Australia, Germany, Spain, United Kingdom, Italy, Poland
Source: ClinicalTrials.govOpened for recruitment
NCT03363373 · Phase 2 · Canada, Germany, Denmark, Spain, France, United Kingdom
Source: ClinicalTrials.govOpened for recruitment
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899 · Phase 1/2 · Germany, Spain, France, United Kingdom, Italy, Netherlands
Source: ClinicalTrials.govClosed for recruitment
NCT03643276 · Phase 3 · Austria, Australia, Switzerland, Czechia, Germany, Israel
Source: ClinicalTrials.govOpened for recruitment
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
NCT05417789 · Phase 3 · Austria, Belgium, Canada, Switzerland, Spain, France
Source: ClinicalTrials.govOpened for recruitment
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
NCT02066220 · Phase 2/3 · Austria, Belgium, Switzerland, Czechia, Germany, Denmark
Source: ClinicalTrials.govClosed for recruitment
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT03590171 · Phase 2 · Austria, Australia, Belgium, Czechia, Germany, Denmark
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
NCT05328258 · Phase 3 · Sweden
Source: ClinicalTrials.govClosed for recruitment
NCT03838042 · Phase 1/2 · Austria, Australia, Switzerland, Germany, France, Netherlands
Source: ClinicalTrials.govClosed for recruitment
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
NCT04793919 · Phase 2 · Belgium, Czechia, Germany, Denmark, Spain, France
Source: ClinicalTrials.govClosed for recruitment
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
NCT07032285 · Phase 2 · Spain
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Not yet recruiting
NCT07134088 · Phase 1/2 · France, Italy, Japan, Netherlands, United States
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
NCT05465174 · Phase 2 · Australia, Germany, France, Netherlands, United States
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Not yet recruiting
NCT02735083 · Phase 1 · Spain, France, United Kingdom, Japan, United States
Source: ClinicalTrials.govOpened for recruitment
Paediatric Hepatic International Tumour Trial
NCT03017326 · Phase 3 · Austria, Belgium, Switzerland, Czechia, Germany, Spain
Source: ClinicalTrials.govOpened for recruitment
NCT05217446 · Phase 2 · Australia, Belgium, Canada, Czechia, Germany, Denmark
Source: ClinicalTrials.govClosed for recruitment
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
NCT01913106 · Phase 1/2 · United States
Source: ClinicalTrials.govOpened for recruitment
IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE
NCT07521202 · No phase · Germany
Source: ClinicalTrials.govNew in the registry
Retroperitoneal Tumor Registry
NCT07915895 · No phase · China
Source: ClinicalTrials.govClosed for recruitment
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
NCT04796012 · Phase 1/2 · United States
Source: ClinicalTrials.govOpened for recruitment
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
NCT04837547 · Phase 1 · United States
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
A Study of Avutometinib for People With Solid Tumor Cancers
NCT06104488 · Phase 1 · United States
Source: ClinicalTrials.govNew in the registry
Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma
NCT07916389 · Phase 2 · United States
Source: ClinicalTrials.govNew in the registry
Multi-center Prospective Validation of Real-Time AI-EGGIM System
NCT07915843 · No phase · China
Source: ClinicalTrials.govPhase changed: No phase → Phase 3
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
NCT02653118 · Phase 3 · Denmark, Norway, Sweden
Source: ClinicalTrials.govPhase changed: No phase → Phase 1/2
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06508775 · Phase 1/2 · Germany
Source: ClinicalTrials.govPhase changed: No phase → Phase 2
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309 · Phase 2 · Austria, Australia, Belgium, Canada, Switzerland, Germany
Source: ClinicalTrials.govPhase changed: No phase → Phase 1
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051 · Phase 1 · Germany
Source: ClinicalTrials.govClosed for recruitment
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT05440617 · No phase · United States
Source: ClinicalTrials.govOpened for recruitment
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
NCT06323447 · No phase · Spain, United States
Source: ClinicalTrials.gov
New reviews, guidelines and randomised trials in PubMed
Systematic review
Head and neck pathology · PubMed
Randomised trial
Psycho-oncology · PubMed
Systematic review
Frontiers in oncology · PubMed
Randomised trial
Long-term effects of a parenting program for advanced cancer: A randomized controlled trial.
Palliative & supportive care · PubMed
Meta-analysis
British journal of hospital medicine (London, England : 2005) · PubMed
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
Phase 1Ended 3 Nov 2026
No phaseEnded 1 Nov 2026
Withdrawn before start0 participants
NCT06116318
A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia
Reason given: The test for c-kit was not set up and replaced by NGS MRD
Phase 2Ended 31 Oct 2026
Withdrawn before start0 participants
NCT04267913
Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)
Reason given: The pharmaceutical company sold the compound and pulled out.
Early Phase 1Ended 28 Oct 2026
Completed30 participants
NCT03893487
Fimepinostat in Treating Brain Tumors in Children and Young Adults
No phaseEnded 14 Oct 2026
Completed16 participants
NCT05440617
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
No phaseEnded 8 Oct 2026
Completed243 participants
NCT07091942
Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
No phaseEnded 1 Oct 2026
Completed120 participants
NCT07591571
To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC
No phaseEnded 1 Oct 2026
Completed17188 participants
NCT07807202
Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up
No phaseEnded 30 Sept 2026
Completed347 participants
NCT05151718
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
No phaseEnded 30 Sept 2026
Completed4341 participants
NCT07903077
Clinical Spectrum and Long-term Outcomes of Congenital Biliary Dilatation
Phase 2Ended 29 Sept 2026
Completed74 participants
NCT07461831
CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma
Phase 2/3Ended 22 Sept 2026
Stopped early2 participants
NCT06820957
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Reason given: Drug supply issues
No phaseEnded 18 Sept 2026
Completed90 participants
NCT07263620
An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy
Phase 4Ended 13 Sept 2026
Stopped early49 participants
NCT07320534
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Reason given: Interim analysis showed no significant benefit of levofloxacin. Prolonged antibiotic use may increase adverse effects and resistance. Limited funding and the approaching end of the study period also supported early termination.
No phaseEnded 10 Sept 2026
Completed4 participants
NCT07374692
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Phase 1Ended 8 Sept 2026
Completed13 participants
NCT04295759
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Phase 3Ended 7 Sept 2026
Completed122 participants
NCT06935409
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
No phaseEnded 6 Sept 2026
No phaseEnded 1 Sept 2026
Completed59 participants
NCT07088783
The Effect of Mobile Application-Based Education Developed According to Orem's Self-Care Model in Multiple Myeloma Patients
No phaseEnded 31 Aug 2026
Completed43 participants
NCT07833631
A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma
Show more
No phaseEnded 30 Aug 2026
Paused20 participants
NCT04339517
Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer
Reason given: Low accrual
Phase 3Ended 30 Aug 2026
No phaseEnded 30 Aug 2026
Completed6190 participants
NCT06856902
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
Phase 1Ended 26 Aug 2026
Phase 2Ended 25 Aug 2026
Phase 1/2Ended 24 Aug 2026
Stopped early634 participants
NCT03145857
A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
Reason given: The market approved 68Ga-DOTATATE (NETSPOT(R)) is now approved for public funding in Alberta and is considered standard of care. Furthermore, the manufacturer of the study Investigational Product (IP) is no longer supplying the IP.
No phaseEnded 18 Aug 2026
Completed195 participants
NCT02743741
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
- Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to 177Lu-DOTATATE in Neuroendocrine Tumors. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026
No phaseEnded 14 Aug 2026
Completed839 participants
NCT02296450
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
No phaseEnded 14 Aug 2026
Completed70 participants
NCT07882069
Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia
Phase 1Ended 13 Aug 2026
Withdrawn before start0 participants
NCT05168748
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
Reason given: Sponsor's decision
No phaseEnded 10 Aug 2026
Completed79 participants
NCT07606170
The Impact of Fatigue on Quality of Life and Activities of Daily Living in Pediatric Oncology Patients
No phaseEnded 10 Aug 2026
Completed2500 participants
NCT03035500
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Phase 2Ended 4 Aug 2026
Completed30 participants
NCT03587662
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Phase 1/2Ended 3 Aug 2026
Completed374 participants
NCT00911560
Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma
No phaseEnded 1 Aug 2026
No phaseEnded 1 Aug 2026
No phaseEnded Jul 2026
Withdrawn before start0 participants
NCT05112458
Cope 360 App for Caregivers of Children With Cancer
Reason given: Grant funding ended prior to enrolling any participants.
No phaseEnded 31 Jul 2026
Completed100 participants
NCT07367997
Comparative Effectiveness of Verbal Instruction Versus Simulation Video Education Among Cancer Patients Undergoing Radiation Therapy
Phase 1Ended 31 Jul 2026
Stopped early10 participants
NCT05262673
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
No reason given in the registry.
Phase 1Ended 31 Jul 2026
Stopped early10 participants
NCT05277753
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early100 participants
NCT03535246
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early100 participants
NCT03125577
Combination CAR-T Cell Therapy Targeting Hematological Malignancies
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early100 participants
NCT04085159
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
No reason given in the registry.
Phase 1Ended 31 Jul 2026
Stopped early30 participants
NCT03170141
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early60 participants
NCT05436509
CD19/79b Bi-specific CAR-T Cell Therapy
No reason given in the registry.
No phaseEnded 31 Jul 2026
Stopped early200 participants
NCT03050190
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early100 participants
NCT04427449
4SCAR-CD44v6 T Cell Therapy Targeting Cancer
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early100 participants
NCT04430530
4SCAR-T Therapy Post CD19-targeted Immunotherapy
No reason given in the registry.
No phaseEnded Jul 2026
Completed400 participants
NCT02938858
French Registry of First-line Treatment of Acute Promyelocytic Leukemia
No phaseEnded 31 Jul 2026
Completed12 participants
NCT06345391
Co-creation of Pain Science Education for Children Living Beyond Cancer
Phase 1/2Ended 31 Jul 2026
Stopped early60 participants
NCT05437328
GD2/CD56 Bi-specific CAR-T Cell Therapy
No reason given in the registry.
Phase 2Ended 31 Jul 2026
Completed50 participants
NCT04876456
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Phase 1/2Ended 31 Jul 2026
Stopped early60 participants
NCT05437341
PSMA/CD70 Bi-specific CAR-T Cell Therapy
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early10 participants
NCT04010877
Multiple CAR-T Cell Therapy Targeting AML
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early20 participants
NCT03362606
Engineered Immune Effectors Against Ovarian Cancer
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early20 participants
NCT03362619
Engineered Immune Effectors Against Cervical Cancer
No reason given in the registry.
Phase 4Ended 28 Jul 2026
No phaseEnded 24 Jul 2026
Completed50 participants
NCT05911269
Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
Phase 2Ended 24 Jul 2026
Phase 3Ended 20 Jul 2026
Not medical advice. fetched 10 Nov 2026